Covidien plc's Technology Platform to Diagnose Early Lung Cancer Part of New Guidelines of American College of Chest Physicians

Published: May 21, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MINNEAPOLIS--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that its superDimension Electromagnetic Navigation Bronchoscopy (ENBâ„¢) system, the first technology of its kind, is included in the new American College of Chest Physicians (ACCP) guidelines to aid in diagnosing and managing lung cancer. The evidence-based clinical practice guidelines were released by the ACCP earlier this month.

Help employers find you! Check out all the jobs and post your resume.

Back to news